X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare with Fulford India - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs FULFORD INDIA - Comparison Results

FULFORD INDIA 
   Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES FULFORD INDIA ALKEM LABORATORIES/
FULFORD INDIA
 
P/E (TTM) x - 398.8 - View Chart
P/BV x 6.1 6.2 98.9% View Chart
Dividend Yield % 0.7 0.1 833.2%  

Financials

 ALKEM LABORATORIES   FULFORD INDIA
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
FULFORD INDIA
Mar-14
ALKEM LABORATORIES/
FULFORD INDIA
5-Yr Chart
Click to enlarge
High Rs1,589942 168.7%   
Low Rs1,232450 273.8%   
Sales per share (Unadj.) Rs417.5691.4 60.4%  
Earnings per share (Unadj.) Rs56.311.5 491.2%  
Cash flow per share (Unadj.) Rs64.715.4 421.3%  
Dividends per share (Unadj.) Rs12.702.00 635.0%  
Dividend yield (eoy) %0.90.3 313.3%  
Book value per share (Unadj.) Rs292.9380.0 77.1%  
Shares outstanding (eoy) m119.573.90 3,065.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.41.0 335.6%   
Avg P/E ratio x25.160.7 41.3%  
P/CF ratio (eoy) x21.845.3 48.1%  
Price / Book Value ratio x4.81.8 262.9%  
Dividend payout %22.617.4 129.3%   
Avg Mkt Cap Rs m168,6532,714 6,213.3%   
No. of employees `000NA0.4 0.0%   
Total wages/salary Rs m9,171505 1,816.1%   
Avg. sales/employee Rs ThNM6,073.0-  
Avg. wages/employee Rs ThNM1,137.4-  
Avg. net profit/employee Rs ThNM100.7-  
INCOME DATA
Net Sales Rs m49,9152,696 1,851.2%  
Other income Rs m1,645125 1,311.9%   
Total revenues Rs m51,5612,822 1,827.2%   
Gross profit Rs m8,482-46 -18,280.8%  
Depreciation Rs m1,00615 6,617.1%   
Interest Rs m67110 7,058.9%   
Profit before tax Rs m8,45154 15,563.5%   
Minority Interest Rs m-1140-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,60610 16,729.2%   
Profit after tax Rs m6,73145 15,058.6%  
Gross profit margin %17.0-1.7 -987.5%  
Effective tax rate %19.017.7 107.5%   
Net profit margin %13.51.7 813.5%  
BALANCE SHEET DATA
Current assets Rs m27,0621,738 1,556.8%   
Current liabilities Rs m15,324545 2,813.2%   
Net working cap to sales %23.544.3 53.1%  
Current ratio x1.83.2 55.3%  
Inventory Days Days6748 137.2%  
Debtors Days Days414 958.9%  
Net fixed assets Rs m12,61012 105,962.2%   
Share capital Rs m23939 613.1%   
"Free" reserves Rs m34,4901,443 2,390.1%   
Net worth Rs m35,0271,482 2,363.5%   
Long term debt Rs m1,2120-   
Total assets Rs m54,3872,077 2,618.9%  
Interest coverage x13.66.7 202.5%   
Debt to equity ratio x00-  
Sales to assets ratio x0.91.3 70.7%   
Return on assets %13.62.6 521.5%  
Return on equity %19.23.0 637.1%  
Return on capital %24.94.3 577.4%  
Exports to sales %12.90-   
Imports to sales %3.124.5 12.6%   
Exports (fob) Rs m6,461NA-   
Imports (cif) Rs m1,540659 233.6%   
Fx inflow Rs m6,56317 38,158.7%   
Fx outflow Rs m3,012673 447.4%   
Net fx Rs m3,552-656 -541.4%   
CASH FLOW
From Operations Rs m7,25990 8,065.0%  
From Investments Rs m1,864105 1,782.2%  
From Financial Activity Rs m-9,273-14 65,763.8%  
Net Cashflow Rs m-150181 -83.1%  

Share Holding

Indian Promoters % 66.9 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 33.1 3.8 871.1%  
FIIs % 0.0 0.1 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 21.2 -  
Shareholders   68,381 4,783 1,429.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   DIVIS LABORATORIES  GLENMARK PHARMA  SUN PHARMA  FRESENIUS KABI ONCO.  FDC LTD.  

Compare ALKEM LABORATORIES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Down Over 290 Points; Metal Stocks Witness Losses(11:30 am)

After opening the day in the red, Indian share markets continued to witness selling pressure on the back of North Korea tensions.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

India's Big and Messy Real Estate Ponzi Scheme, Just Got Messier(Vivek Kaul's Diary)

Sep 11, 2017

The question is, whether real estate buyers are financial creditors or not.

The Recipe to Over 60% Returns in Less Than a Year(The 5 Minute Wrapup)

Sep 9, 2017

Short term crisis in some companies could unveil some great investing opportunities.

Feeling Left Out? Two Opportunities to Make Money in This Market(Daily Profit Hunter)

Sep 13, 2017

Nifty is above 10,000 once again. Have you missed the bus?

Introducing Smart Contrarian: The Blueprint for Big Profits from Small Investments

Sep 18, 2017

Welcome to a bold, new initiative designed for the truly contrarian investor.

How To Link Aadhaar With Your Mutual Fund Investments(Outside View)

Sep 11, 2017

The Government has extended the linking of the unique Aadhaar number to nearly all financial transactions.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Sep 22, 2017 01:46 PM

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES - WYETH LTD COMPARISON

COMPARE ALKEM LABORATORIES WITH

MARKET STATS